GUELPH, ON, April 11, 2024 /CNW/ - BIOREM Inc. (TSXV:BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com). FINANCIAL HIGHLIGHTS: In '000's except earnings per share Thee-months ended Twelve-months ended December 31 December 31 2023 2022 2023 2022 Revenue 12,207 10,911 25,165 28,863 Gross profit 4,407 4,853 7,022 8,762 Operating Expenses 1,329 2,594 3,959 6,121 Ebitda* 3,270